According to our latest research, the infectious disease in-vitro diagnostics market size reached USD 33.4 billion in 2024 at a robust growth pace, driven by increasing demand for rapid and accurate diagnostic solutions. The market is registering a compound annual growth rate (CAGR) of 4.9% and is forecasted to reach USD 51.9 billion by 2033. The growth of this market is primarily propelled by the rising global burden of infectious diseases, technological advancements in diagnostic platforms, and heightened awareness among healthcare providers and patients regarding early disease detection. https://growthmarketreports.com/report/infectious-disease-in-vitro-diagnostics-market-global-industry-analysis